October 20, 2021 Comments Off on Updating the DrugPatentWatch Biologics Module Posted in: Insights, Update Before the passage of the Biologic Patent Transparency Act DrugPatentWatch’s biologic patent data was cited as a reason why the law should not be passed. Thankfully, the Act advanced, and…
The post Updating the DrugPatentWatch Biologics Module appeared…
October 20, 2021 Comments Off on Bayer’s in silico ADMET platform: a journey of machine learning over the past two decades Posted in: Guest content, Insights This paper was originally published by Andreas H. Göller, Lara Kuhnke, Floriane Montanari, Anne Bonin, Sebastian Schneckener, Antoniuster Laak, Jörg Wichard, Mario Lobell, and Alexander Hillisch in Drug Discovery Today…
The post Bayer’s in silico ADMET…